NCT07088913 2026-03-03
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
AstraZeneca
Phase 1 Completed
Clinical Trials
8 trialsNCT07241065 2025-11-21
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
AstraZeneca
Phase 1 Not yet recruiting
NCT06677957 2025-01-03
A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants
Genentech, Inc.
Phase 1 Completed
NCT05411146 2024-05-24
A Study Investigating the Safety, Absorption, and Elimination of Radioactively Labeled Etrumadenant, a New Compound in the Treatment of Cancer
Arcus Biosciences, Inc.
Phase 1 Completed
NCT05395117 2023-12-13
A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin
AstraZeneca
Phase 1 Completed
NCT05045638 2023-08-14
Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Amgen
Phase 1 Completed
NCT05708573 2023-04-14
Potential Drug Interaction Between ALXN2040 and Rosuvastatin
Alexion Pharmaceuticals, Inc.
Phase 1 Completed
NCT01674322 2014-11-05
A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male Participants
Janssen Research & Development, LLC
Phase 1 Completed